Terri Harchar is promoted to lead Axiom US

The Creative Engagement Group (TCEG) has promoted Terri Harchar to the newly created role of Managing Director of Axiom US, its life sciences training and scientific engagement division.

Terri was previously executive VP, Training & Scientific Strategy at Axiom, where she led Axiom’s Scientific and Instructional Design teams to develop and deliver award-winning strategies for clients. Her promotion to the new role, where she will oversee day-to-day operations at Axiom’s US division, follows the announcement that Mike Ballas, Global CEO of Axiom, has been appointed EVP, Healthcare at TCEG North America in addition to his role as CEO Axiom.

In her new role, Terri will help to drive the growth agenda for Axiom and continue to build its reputation for scientific excellence innovation and creativity. Terri will also partner with Madelaine Allen, Head of Axiom Europe, and work with the client engagement team to build on The Creative Engagement Group’s momentum with its clients.

Having joined Axiom in 2007, Terri brings 14 years’ experience of creating pharmaceutical training content to her new role. Her previous positions at Axiom include Scientific Director and Vice-President, Scientific Content. In her new role as Managing Director, Terri will report to Mike Ballas and Russ Lidstone, Group CEO at The Creative Engagement Group.

Terri Harchar, Managing Director, Axiom US, said:

“When I think of Axiom, I think of exceptionally talented people, best-in-class life science training, and the strong partnerships we’ve developed with our clients and our peers in the industry. This team is truly passionate about what we do and how we do it. That’s why I’m so excited for the opportunity to continue to grow and develop Axiom as part of the evolution of The Creative Engagement Group in North America, alongside a group of individuals I respect so much.”